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1. Introduction 
In contrast o the T-even phages, coliphages T, and 
Ta produce their own RNA polymerase [ 1,2]. T, 
RNA polymerase, isolated from the soluble fraction of 
disrupted infected bacteria has been claimed by Sum- 
mers and Siegel [3] to transcribe only late T, genes 
in vitro. The data of Studier [4] indicate that early 
phage proteins are produced also late in the infection 
period. The question arises at which time and by which 
of the two polymerases the mRNA’s coding for these 
early proteins are transcribed. The activity of TV RNA 
polymerase can be distinguished from E. coli RNA 
polymerase since only the latter is inhibited by rif- 
ampicin [ 11. 
The stability of T7 mRNA was studied by Summers 
[5], who determined the mRNA half-life to be approx. 
15 min. One of us showed that early mRNA was labelled 
during a 3 min pulse 14 to 17 min after infection at 
30°C [6]. It is therefore plausible that early phage pro- 
teins synthesized at late times are coded by mRNA syn- 
thesized both at early and late times after infection. 
Recently Scherzinger et al. [7] showed that early 
phage proteins (ligase and lysozyme) are synthesized 
in vitro in a system where T7 RNA polymerase was 
the only RNA polymerase present. This suggests hat 
early mRNA’s are transcribed by TV RNA polymerase 
in vivo. In this paper we show that in vitro mRNA syn- 
thesized by T7 RNA polymerase ispartially competed 
against by class I mRNA in hybridization-competition 
experiments, thus confirming the results of Scherzinger 
et al. [7]. Furthermore, we found that T, RNA poly 
merase is responsible for at least part of the early T7 
mRNA synthesis taking place in the late period. 
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2. Materials and methods 
2.1. Chemicals 
All chemicals used were of highest commercial 
grade. Unlabelled triphosphates and Trizma buffer 
were from Sigma Chemical Co. [5-3H]Uracil and 
[5-3H]uridine-5’-triphosphate were from The Radio- 
chemical Centre, Amersham. Rifampicin was a gift 
from CIBA. 
2.2. Bacterial strains and phages 
E. coli B, E. coli 011 (permissive host for T7 amber 
mutants), T7 wild type, and TV am 23 were gifts from 
Prof. W. Studier. E. coli BE rs 30 was from Prof. R.H. 
Epstein. 
2.3. Growth conditions and isolation of phages 
The bacteria were grown at 30°C on a slightly mod- 
ified casamino acid-glycerol medium [8]. The same 
medium was used for phage propagation. Phage was 
purified according to the method of Yamamoto [9]. 
When T, was purified for strand separation, the meth- 
od described by Biivre [lo] was employed. Membranes 
from phage infected cells were isolated as described by 
Haarr [ 111. The temperature for all phage infections 
was 30°C. 
2.4. Hybridization techntques 
Hybridization and hybridization competition ex- 
periments were performed according to the methods 
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of Hall et al. [ 121. The hybrids were collected on nitro- 
cellulose filters, and the radioactivity was determined 
in the nuclear Chicago scintillation counter, using 
toluene-PPO-PQPQP scintillation mixture (10 ml/ 
vial). 
2.5. DNA preparation 
Native T, DNA was isolated from purified phage 
by phenol extraction [ 131, Isolated DNA preparations 
had Aa6e/A~se ratios of 1.88 to 1.95. The absorbance 
was measured in a Zeiss PMQ II spectrophotometer. 
The separation of T, .DNA strands was carried out 
according to Bovre [lo]. 
2.6. RNA polymerase assay 
The T, RNA polymerase specific assay (0.25 ml) 
contained 5.5 X 1tJ4 M ATP; 3.5 X lp M CTP and 
GTP; 1.2 X 1(r4 M [3H]UTP (1.4 Ci/mM); 5 mM 
/I-mercaptoethanol; 40 mM Tris-HCl pH 7.9; 20 mM 
MgClz ; 25 pg/rnl native T, DNA; 20 pg/ml rifampicin 
and membrane suspension (containing the RNA-poly- 
merase) to a final cont. of 150 pg/ml protein. The 
incubation temperature was 30°C. When assaying the 
E. coli RNA polymerase rifampicin was omitted, the 
MgCl* concentration was changed to 8 mM, and 0.5 
M KC1 was added. 
Radioactivity of TCA precipitable material was 
determined. For in vitro RNA production the assay 
mixture was scaled up to 4 ml, and the reaction was 
allowed to proceed for 30 min. 
2.7. RNA isolation 
2.7.1. In vivo RNA 
At the time desired, the infected cells were poured 
on frozen medium (40 g/l00 ml culture) containing 
lO-* M NaN3. Further RNA isolation was performed 
as described by Hall and Crouch [ 141. The pulse- 
labelled RNA was isolated similarly except the etha- 
nol precipitation was omitted. 
Class I RNA was obtained in two ways: i) E. coli B 
cells growing in the log phase (about 5 X lo* cells/ml) 
were infected by T, phage at an m.o.i. of 17 to 20 at 
5 min after the addition of 400 E.cg chloramphenicol 
per ml. At 8 min after infection, the culture was pour- 
ed on 0.4 vol crushed, frozen medium. Further isola- 
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tion was as described for in vivo RNA. ii) Class I RNA 
was also isolated from E. coli B cells infected with TV 
am 23. In this case class I RNA is the only phage spe- 
cific RNA synthesized [ 51. 
2.7.2. Isolation of RNA synthesized in vitro 
At the end of the in vitro RNA synthesis, DNAase 
(final cont. 20 pg/ml) was added and the solution was 
incubated at 37°C for 10 min. Then 25% SDS to a 
final cont. of 0.5% and 1 vol of freshly distilled phenol 
saturated with water was added. This mixture was 
shaken for 3 min at 60°C and then for 30 min in the 
cold. The extraction was repeated twice. Finally, the 
RNA solution was dialyzed against 3 X 1 II of 0.5 M 
KCl, 0.01 M Tris-HCl pH 7.3 for 24 hr at 4°C. The 
labelled RNA was always tested for absorption on 
nitrocellulose filters. The amount of radioactivity on 
the filter did not exceed 5% of the total acid precipi- 
table label. 
3. Results and discussion 
3.1. In vivo experiments 
Summers and Siegel [3] have shown that the devel- 
opment of T, phage becomes resistant to rifampicin 
when the drug is added later than 3 to 4.5 min after 
T, infection at 30°C. From these observations they 
concluded that all class I RNA synthesis by host RNA 
polymerase has been initiated by that time. Their re- 
sults do not exclude the synthesis of class I RNA late 
in the infection period. To investigate this, mRNA 
was pulse-labelled in uivo between 14 and 17 min af- 
ter infection at 30°C. The RNA was isolated as de- 
scribed in Methods, and characterized by hybridiza- 
tion competition experiments [ 121. Unlabelled class 
I RNA should not compete with the 1abeIled in vivo 
RNA if class I RNA was not synthesized during the 
pulse. In fig. 1 the hybridization competition curve is 
shown. Approx. 30% competition is found using class 
I RNA as competitor. This observation shows that class 
I RNA is produced also late in the infection period. 
Thus, the question arises whether the host RNA poly- 
merase is still active, or if it is the phage induced RNA 
polymerase which transcribes the early T, genes. When 
E. coli cells sensitive to rifampicin are infected with T, 
in the presence of the drug, the host RNA polymerase 
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Fig. 1. Hybridization competition between in vivo class I RNA 
and in vivo 14 to 17 min labelled ( 3H]uracil RNA. The class 
I RNA was isolated from E. coli B cells infected by T7 phaga 
at an m.o.i. of about 20 at 5 min after the addition of 400 pg/ 
ml chloramphenicol. The cells were harvested 8 min after in- 
fection and the RNA isolated as described in Methods. The 
14 to 17 min RNA was labelled with [S-3H]uracil. The hybrid- 
ization mixture in 0.5 ml, 0.5 M KCl, 0.01 M Tris-HCl, pH 7.3 
contained 2.5 pg/ml denatured double stranded T7 DNA, 
labelled RNA and the unlabelled competitor RNA at the 
amount indicated. (o-o-o) 14 to 17 min in vivo 13H]RNA, 
produced in the presence of rifampicin, E. coli BE rs 20 being 
the host. RNA concentration, 8.2 Mg/ml. The specific activity 
of the labelled RNA was 1750 cpm/pg. (A-A-4) 14 to 17 
min in vivo i3H]RNA produced in absence of rifampicin, 
E. coli being the host. The reaction mixture contained 10 
Crg/ml of the labelled RNA (2500 cpm/pg). The reaction tem- 
perature was 67°C and the incubation time was 3 hr. 
should be blocked and the T7 RNA polymerase should 
be responsible for the entire RNA synthesis [I]. The 
above experiment was repeated, using E. coli BE rs 30, 
which is rifampicin sensitive. Rifampicin was added 
10 min after infection, to a final cont. of 50 E.cglml. 
Control experiments with the sensitive bacteria show- 
ed normal phage production. Bacterial growth ceased 
immediately in the presence of the drug. The results 
of hybridization-competition experiments with in 
viva RNA labelled in the presence of rifampicin are 
presented in fig. 1. These agree well with the results 
using RNA synthesized in the absence of the drug. It 
is thus concluded that T7 RNA polymerase is capable 
of transcribing early T7 genes in viva. 
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Fig. 2. In vitro assay of RNA polymerase in membrane prep 
arations from E. coli BE rs 30 cells infected with T7 and har- 
vested 12 min after infection. The isolation of the membrane 
and the assay conditions were as described in Methods. Assay 
conditions for the host RNA polymerase were altered so that 
the MgCla and KC1 concentrations were 8 mM and 0.5 M re- 
spectively. (u-m~e) T7 RNA-polymerase activity. (o-a-o) 
T7 RNA-polymerase activity in the presence of 50 Hg/ml rif- 
ampicin. (o-o-o) Host RNA-polymerase activity. (e-e-e) 
Host RNA-polymerase activity in the presence of rifampicin 
(50 rrg/ml). 
3.2. In vitro experiments 
To see whether or not E. coli RNA polymerase is 
active during the late period of T7 infection, mem- 
brane preparations i olated according to Haarr [ 1 l] 
were used as a source of RNA polymerase for in vitro 
assays (fig. 2). A very low RNA polymerase activity 
was observed under the assay conditions optimal for 
host enzyme. 
Rifampicin did not influence the activity signif& 
cantly. However, by increasing the isotopic concen- 
tration, we found a decrease in host RNA polymerase 
activity in the presence of rifampicin. The T7 RNA 
polymerase, in contrast, is very active, and shows the 
normal insensitivity towards rifampicin. The RNA syn- 
thesized by cell membranes from E. coli B cells infect- 
ed with T7 and harvested 15 min after infection was 
characterized by hybridization-competition experi- 
ments (fig. 3). This in vitro RNA was found to hybrid- 
ize with the r-strand of T7 DNA only [lo]. By a com- 
parison of the in vivo results with those obtained in 
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Fig. 3. Hybridization-competition between in vivo class I RNA 
and in vitro 13H]RNA synthesized by membrane-bound T7 
RNA-polymerase. Membranes were isolated 15 min after pha- 
ge infection at 30°C. The isolation of membranes, the in vitro 
RNA synthesis and RNA isolation were performed as described 
in Methods. The hybridization conditions were the same as de- 
scribed in the legend to fig. 1. The concentration of denatured 
double stranded T7 DNA was 3 fig/ml and of the labelled RNA 
3.5 Mg/ml (specific activity 47 000 cpm/&. 
vitro, we conclude that the phage-specific RNA poly- 
merase is capable of transcribing the complete T7 
genome in vivo as well as in vitro. 
Further evidence suggesting that the phage-specific 
RNA polymerase transcribes class I RNA was obtain- 
ed using RNA polymerase partially purified from iso- 
lated cell membranes [6]. This enzyme preparation 
was completely dependent on externally added T7 
DNA. By hibridization-competition experiments the 
RNA produced was found to contain approx. 40% 
class I RNA. 
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